Tuberculosis trials in Botswana

2 of 2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  Where

  Gaborone, Molepolole

  Age

  Up to 13 years

  People

  144 worldwide

  Run by

  National Institute of Allergy and Infectious Diseases (NIAID)

  See details and how to joinNCT07124559
• Phase 2Not yet taking people in Botswana
  A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

  Where

  Gaborone

  Age

  13 years and over

  People

  900 worldwide

  Run by

  National Institute of Allergy and Infectious Diseases (NIAID)

  See details and how to joinNCT07595042